Novel therapeutic targets for diabetic nephropathy.
Novel therapeutic targets for diabetic nephropathy.
批准号:
17590828
负责人:
SHIKATA Kenichi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
糖尿病肾病是终末期肾功能衰竭的主要原因。多种机制,包括蛋白激酶C的激活、晚期糖基化终产物和转化生长因子(TGF)- β的过度表达,被认为参与了糖尿病肾病的发病机制。然而,炎症过程在糖尿病微血管并发症发病机制中的意义尚不清楚。巨噬细胞的积累和白细胞粘附分子和趋化因子的过度表达在糖尿病人肾脏组织中是突出的。我们之前证明了细胞间粘附分子(ICAM)-1介导巨噬细胞浸润到糖尿病肾脏。为了寻找新的治疗糖尿病肾病的靶点,我们在ICAM-1缺陷(ICAM-1(-/-))小鼠和ICAM-1(+/+)小鼠中诱导糖尿病或5/6肾切除术,并在6个月的时间内观察肾脏病理。与ICAM-1(+/+)小鼠相比,糖尿病ICAM-1(-/-)小鼠或5/6肾切除术ICAM-1(-/-)小鼠的巨噬细胞浸润、蛋白尿和肾组织损伤均明显受到抑制。我们利用DNA微阵列系统研究了这些小鼠肾脏的基因表达谱。骨桥蛋白、胆囊收缩素(CCK)和清除率受体A等基因在糖尿病或5/6肾切除的ICAM-1(+/+)小鼠肾脏中表达上调,而与ICAM-1(+/+)小鼠相比,这些基因在糖尿病或5/6肾切除的ICAM-1(-/-)小鼠肾脏中的表达水平降低。与野生型小鼠相比,清道夫受体A缺陷小鼠在诱导糖尿病后表现出蛋白尿减少和肾损伤。与野生型小鼠相比,cck受体缺陷小鼠在5/6次肾切除术后肾损伤得到改善。我们的研究结果表明微炎症参与了糖尿病肾病的发病机制。CCK、清道夫受体A和骨桥蛋白可能是治疗糖尿病肾病的新靶点。
英文摘要
Diabetic nephropathy is a leading cause of end-stage renal failure. Several mechanisms, including activation of protein kinase C, advanced glycation end products, and overexpression of transforming growth factor (TGF)-beta, are believed to be involved in the pathogenesis of diabetic nephropathy. However, the significance of inflammatory processes in the pathogenesis of diabetic microvascular complications is poorly understood. Accumulation of macrophages and overexpression of leukocyte adhesion molecules and chemokines are prominent in diabetic human kidney tissues. We previously demonstrated that intercellular adhesion molecule (ICAM)-1 mediates macrophage infiltration into the diabetic kidney. To find a novel therapeutic target for diabetic nephropathy, we induced diabetes or 5/6 nepphrectomy in ICAM-1-deficient (ICAM-1(-/-)) mice and ICAM-1(+/+) mice and examined the renal pathology over a period of 6 months. The infiltration of macrophages, albuminuria anc renal tissue injuries were markedly suppressed in diabetic ICAM-1(-/-) mice or 5/6 nephrectomized ICAM-1(-/-) mice compared with ICAM-1(+/+) mice. We investigated the gene expression profiles in the kidneys of these mice using DNA microarray system. Several genes including osteopontin, cholecystokinin (CCK) and scavenger receptor A are up-regulated in the kidneys of diabetic or 5/6 nephretomized ICAM-1(+/+) mice, while the expression levels of these genes were decreased in diabetic or 5/6 nephrectomized ICAM-1(-/-) mice as compared to ICAM-1(+/+) mice. Scavenger receptor A deficient mice revealed diminished albuminuria and renal injuries after induction of dianetes as compared with wild type mice. Renal injuries were ameliorated in CCK-receptor deficient mice after 5/6 nephrectomy as compared with wild type mice. Our results indicate that microinflammation is involved in the pathogenesis of diabetic nephropathy. CCK, scavenger receptor A and osteopontin may be novel therapeutic target for diabetic nephropathy.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.diabres.2006.09.004
发表时间:
2007-06
期刊:
Diabetes research and clinical practice
影响因子:
5.1
作者:
[R. Yoshikawa;J. Wada;K. Seiki;Takashi Matsuoka;S. Miyamoto;Kenji Takahashi;S. Ota;K. Taniai-]
通讯作者:
R. Yoshikawa;J. Wada;K. Seiki;Takashi Matsuoka;S. Miyamoto;Kenji Takahashi;S. Ota;K. Taniai-
The association of C-reactive protein with an oxidative metabolite of LDL and its implicationin atherosclerosis
C反应蛋白与LDL氧化代谢物的关联及其在动脉粥样硬化中的意义
DOI:
--
发表时间:
2007
期刊:
J Lipid Res 48
影响因子:
--
作者:
[Tabuchi M, Inoue K, Usui-Kataoka H, Kobayashi K, Teramoto M, Takasugi K, Shikata K, Yamamura M, Ando K, Nishida K, Kasahara J, Kume N, Lopez LR, Mitsudo K, Nobuyoshi M, Yasuda T, Kita T, Makino H, Matsuura E]
通讯作者:
Matsuura E
Edaravone mimics sphingosine-1-phosphate-induced endothelial barrier enhancement in human microvascular endothelial cells. Am J Physiol Cell Physiol. 2007 Nov;293(5):C1523-31.Epub2007Aug8.
Edaravone 模拟 1-磷酸鞘氨醇诱导的人微血管内皮细胞内皮屏障增强。
DOI:
--
发表时间:
2007
期刊:
Am J Physiol Cell Physiol. 263・5
影响因子:
--
作者:
[Omori K, Shikata Y, Sarai K, Watanabe N, Wada J, Goda N, Kataoka N, Shikata K, Makino H.]
通讯作者:
Makino H.
DOI:
10.1681/asn.2004111011
发表时间:
2005-11
期刊:
Journal of the American Society of Nephrology : JASN
影响因子:
--
作者:
[Kosuke Yozai;K. Shikata;Motofumi Sasaki;A. Tone;S. Ohga;H. Usui;S. Okada;J. Wada;Ryo Nagase-Ryo-Nagas]
通讯作者:
Kosuke Yozai;K. Shikata;Motofumi Sasaki;A. Tone;S. Ohga;H. Usui;S. Okada;J. Wada;Ryo Nagase-Ryo-Nagas
DOI:
10.2337/db05-1285
发表时间:
2006-06-01
期刊:
DIABETES
影响因子:
7.7
作者:
[Okada, Tatsuo, Wada, Jun, Makino, Hirofumi]
通讯作者:
Makino, Hirofumi
共 13 条
Development of the novel therapeutic strategy for diabetic nephropathy through anti-inflammatory effects.
-
批准号:21591031
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:SHIKATA Kenichi
-
依托单位:
Exploratory research to development of novel therapeutic strategy for diabetic nephropathy
-
批准号:19590952
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:SHIKATA Kenichi
-
依托单位:
Role of Macrophage in the pathogenesis of diabetic nephropathy and novel therapeutic target.
-
批准号:15590850
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:SHIKATA Kenichi
-
依托单位:
Role of Macrophage in the pathogenesis of diabetic nephropathy revealed by ICAM-1 deficient mice.
-
批准号:13671116
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:SHIKATA Kenichi
-
依托单位:
Application of anti-adhesion molecule therapy for glomerulonephritis -Effects of sulfated oligosaccharides as selectin-blocking agents-
-
批准号:11671036
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:1999
-
负责人:SHIKATA Kenichi
-
依托单位:
Mechanism of inflammatory cell infiltration in the kidney tissue of glomerulonephritis and diabetic nephropathy. -Elucidation of the role of cell adhesion molecules and development of therapeutic drugs.-
-
批准号:06671141
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1994
-
负责人:SHIKATA Kenichi
-
依托单位:
海外基金